What is the long-term trend for TriSalus Life Sciences, Inc.'s derivative liability, noncurrent?

Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s derivative liability, noncurrent has grown at a 226.9% compound annual growth rate (CAGR), from $369K to $12.89M.

TriSalus Life Sciences, Inc. TLSI Derivative Liability, Noncurrent

Derivative Liability, Noncurrent at other companies

SES AISES

$3.59M+125%

EPM

Evolution PetroleumEPM

$808K-53.6%

FitLife Brands, Inc.FTLF

$0—

Biote Corp.BTMD

$1.96M-69.6%

Chord EnergyCHRD

$10.2M+209%

PED

PEDEVCOPED

$11.37M—

Other financials

Income statement

See full

Revenue$8.9M-2.9%

Gross profit$7.7M0.0%

Operating income-$8.4M-14.8%

Net income$1.5M+115%

EPS (diluted)$0.03+108%

Balance sheet

See full

Cash & equivalents$56.6M+324%

Total debt$33.1M+4.4%

Total equity$12.8M+137%

Total assets$71.0M+148%

Cash flow

See full

Operating cash flow-$6.5M-44.0%

CapEx$141.0K-81.3%

Free cash flow-$6.6M-26.0%

Valuation

See full

Market cap$279.45M+49.6%

Enterprise value$255.97M+33.6%

P/S6.2×+1.0×

Profitability

See full

Gross margin85.1%-0.5pp

Operating margin-62.4%-16.8pp

Net margin-60.9%-13.4pp

FCF margin-45.2%-16.8pp

Returns & leverage

See full

Return on equity253.3%—

Debt / equity2.6×—

Current ratio5.8×+3.6×

Where this comes from

Reported directly by TriSalus Life Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilitiesNoncurrent.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s derivative liability, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s derivative liability, noncurrent?: TriSalus Life Sciences, Inc. (TLSI) reported derivative liability, noncurrent of $9.08M in Q1 2026.
How has TriSalus Life Sciences, Inc.'s derivative liability, noncurrent changed year-over-year?: TriSalus Life Sciences, Inc.'s derivative liability, noncurrent decreased by 4.1% year-over-year, from $9.46M to $9.08M.
What is the long-term trend for TriSalus Life Sciences, Inc.'s derivative liability, noncurrent?: Over 3 years (2022 to 2025), TriSalus Life Sciences, Inc.'s derivative liability, noncurrent has grown at a 226.9% compound annual growth rate (CAGR), from $369K to $12.89M.